国际标准期刊号: 2155-6105

成瘾研究与治疗杂志

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • CAS 来源索引 (CASSI)
  • 哥白尼索引
  • 谷歌学术
  • 夏尔巴·罗密欧
  • 打开 J 门
  • Genamics 期刊搜索
  • 学术钥匙
  • 期刊目录
  • 安全点亮
  • 中国知网(CNKI)
  • 电子期刊图书馆
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-世界猫
  • SWB 在线目录
  • 虚拟生物学图书馆 (vifabio)
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • 欧洲酒吧
  • ICMJE
分享此页面

抽象的

Feasibility and Acceptability of Over-The-Counter Distribution of Take-Home Naloxone: A Systematic Review

Mustapha Karikari, Emma Sename Baxey

Introduction: Opioid drugs or narcotic analgesics, are the most prescribed analgesics for effective pain management. Additional desirable effects of opioids lead to its high abuse risk. The most fatal outcome of overdose is death resulting from respiratory depression, hypoxia, brain damage and coma. Naloxone, a fast-acting opioid antagonist is proven to be effective for the reversal of opioid overdose effects, however with limited access. Over-thecounter distribution of take-home naloxone in community pharmacies is a medium of distribution that can increase accessibility to individuals at risk of opioid overdose deaths.

Methods: PubMed, Embase, Web of Science, PsycINFO and the Cochrane library were searched for peer reviewed literature using the main terms; opioids, opioid abuse, opioid overdose deaths, naloxone, take-home naloxone and over-the-counter distribution. Grey literature and other specialists’ websites were also searched. Seven papers met the inclusion criteria for this systematic review.

Results: Selected study results were synthesized qualitatively, and the results of this study indicates that overthe- counter distribution of take-home naloxone is acceptable and feasible in increasing the accessibility of takehome naloxone for the prevention of opioid overdose fatalities.

Conclusion: Over-the-counter distribution of take-home naloxone is an acceptable and feasible novel intervention that can increase the accessibility of this medicine to individuals at risk of opioid overdose deaths. Implementation challenges identified with over-the-counter distribution of take-home naloxone such as cost, lack of appropriately packaged naloxone products for over-the-counter distribution, elaborate licensing and certification procedures for pharmacist and legislations that affect the stocking and dispensing of naloxone, needs to be collaboratively tackled by all stakeholders to achieve successful outcomes of this intervention.

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证。